The APOE4-estrogen-microglia axis in perimenopausal cognitive changes: mechanisms and therapeutic implications
A precision medicine framework for preventing or delaying neurodegenerative progression in high-risk perimenopausal women is proposed, centered on the APOE4-estrogen deficiency-microglia axis.